Tirzepatide treatment and associated changes in β-cell function and insulin sensitivity in people with obesity or overweight with prediabetes or normoglycemia: a post hoc analysis from the SURMOUNT-1 trial
Mari A, Stefanski A, van Raalte DH, et al.
Diabetes Care. 2025:dc250763.
Leggi


